Biblio Discovery — Demo Discovery Service

21 results for "Nicole Concin"

Showing 1–20 · 0.44 seconds · RSS

  1. Journal Article

    The relative risk of second primary cancers in Austria’s western states: a retrospective cohort study

    Oliver Preyer; Nicole Concin; Andreas Obermair et al.

    BMC Cancer, Vol. 17 No. 1 · 2017 · English · DOAJ Scopus

    Abstract Background Cancer survivors are at risk of developing a second primary cancer (SPC) later in life because of persisting effects of genetic and behavioural risk factors, the long-term sequelae of chemotherapy, radiotherapy and the passage of time. This is the first study with Austrian data…

  2. Journal Article Full text

    The Impact of the Duration of Adjuvant Chemotherapy on Survival in Patients with Epithelial Ovarian Cancer - A Retrospective Study.

    Veronika Seebacher; Alexander Reinthaller; Heinz Koelbl et al.

    PLoS ONE, Vol. 12 No. 1 · 2017 · English · DOAJ Scopus

    OBJECTIVE:The aim of the present study was to investigate the prognostic role of the duration of adjuvant chemotherapy in patients with epithelial ovarian, fallopian tube and primary peritoneal cancer (EOC). MATERIALS AND METHODS:Within the present study we retrospectively evaluated the data of 165…

    Also available at: PLOS

  3. Journal Article

    AB0 blood groups and rhesus factor expression as prognostic parameters in patients with epithelial ovarian cancer – a retrospective multi-centre study

    Veronika Seebacher; Stephan Polterauer; Alexander Reinthaller et al.

    BMC Cancer, Vol. 18 No. 1 · 2018 · English · DOAJ Scopus

    Abstract Background AB0 blood groups and Rhesus factor expression have been associated with carcinogenesis, response to treatment and tumor progression in several malignancies. The aim of the present study was to test the hypothesis that AB0 blood groups and Rhesus factor expression are associated…

  4. Journal Article Full text

    Prognostic relevance of pretherapeutic gamma-glutamyltransferase in patients with primary metastatic breast cancer.

    Christine Staudigl; Nicole Concin; Christoph Grimm et al.

    PLoS ONE, Vol. 10 No. 4 · 2015 · English · DOAJ Scopus

    Gamma-glutamyltransferase (GGT) is a known marker for apoptotic balance and cell detoxification. Recently, an association of baseline GGT levels and breast cancer incidence, tumor progression and chemotherapy resistance was shown. The purpose of this study was to evaluate the association of…

    Also available at: PLOS

  5. Journal Article

    Fetal weight estimation at term – ultrasound versus clinical examination with Leopold’s manoeuvres: a prospective blinded observational study

    Oliver Preyer; Heinrich Husslein; Nicole Concin et al.

    BMC Pregnancy and Childbirth, Vol. 19 No. 1 · 2019 · English · DOAJ Scopus

    Abstract Background Fetal weight estimation is of key importance in the decision-making process for obstetric planning and management. The literature is inconsistent on the accuracy of measurements with either ultrasound or clinical examination, known as Leopold’s manoeuvres, shortly before term…

  6. Journal Article

    Gender-related differences in career development among gynecologic oncology surgeons in Europe. European Network of Young Gynecologic Oncologists’ Survey based data

    Tanja Nikolova; Michaela Bossart; Joanna Kacperczyk-Bartnik et al.

    Frontiers in Oncology, Vol. 12 · 2022 · English · DOAJ Scopus

    IntroductionGender-related differences in career development are well known issues in various professions. An international survey on gender-related differences was performed among young gynecologic oncology surgeons in Europe to identify potential gender inequalities in career development.Material…

  7. Journal Article Full text

    γ-Glutamyltransferase and Breast Cancer Risk Beyond Alcohol Consumption and Other Life Style Factors - A Pooled Cohort Analysis.

    Oliver Preyer; Dorthe Johansen; Jessica Holly et al.

    PLoS ONE, Vol. 11 No. 2 · 2016 · English · DOAJ Scopus

    Elevated γ-Glutamyltransferase serum levels are associated with increased risk of overall cancer incidence and several site-specific malignancies. In the present prospective study we report on the associations of serum γ-Glutamyltransferase with the risk of breast cancer in a pooled…

    Also available at: PLOS

  8. Journal Article

    Case Report: Durable response to mirvetuximab soravtansine in a patient with platinum-sensitive ovarian cancer and a diagnosis of myelodysplastic syndrome

    Theresa Steindl-Tomschizek; Teresa Lucia Pan; Christian Sillaber et al.

    Frontiers in Oncology, Vol. 16 · 2026 · English · DOAJ Scopus

    BackgroundHigh-grade serous ovarian cancer is one of the most lethal malignancies in women, typically diagnosed at an advanced stage, treated with debulking surgery, platinum-based chemotherapy and maintenance therapy, and associated with a high risk of recurrence even after optimal treatment…

  9. Journal Article

    A comparison of four technologies for detecting p53 aggregates in ovarian cancer

    Nicole Heinzl; Katarzyna Koziel; Elisabeth Maritschnegg et al.

    Frontiers in Oncology, Vol. 12 · 2022 · English · DOAJ Scopus

    The tumor suppressor protein p53 is mutated in half of all cancers and has been described to form amyloid-like structures, commonly known from key proteins in neurodegenerative diseases. Still, the clinical relevance of p53 aggregates remains largely unknown, which may be due to the lack of…

  10. Journal Article

    Use of Underarm Cosmetic Products in Relation to Risk of Breast Cancer: A Case-Control Study

    Caroline Linhart; Heribert Talasz; Evi M. Morandi et al.

    EBioMedicine, Vol. 21 No. C · 2017 · English · DOAJ Scopus

    Background: Previous studies on breast cancer (BC), underarm cosmetic products (UCP) and aluminum salts have shown conflicting results. We conducted a 1:1 age-matched case-control study to investigate the risk for BC in relation to self-reported UCP application. Methods: Self-reported history of…

  11. Journal Article Full text

    FIGO staging of endometrial cancer: 2023

    Jonathan S. Berek; Xavier Matías‐Guiu; Carien L. Creutzberg et al.

    International Journal of Gynecology & Obstetrics · 2023 · English · OpenAlex

    Abstract Introduction Many advances in the understanding of the pathologic and molecular features of endometrial cancer have occurred since the FIGO staging was last updated in 2009. Substantially more outcome and biological behavior data are now available regarding the several histological types…

    Also available at: OpenAlex

  12. Journal Article

    Part I of GANNET53: A European Multicenter Phase I/II Trial of the Hsp90 Inhibitor Ganetespib Combined With Weekly Paclitaxel in Women With High-Grade, Platinum-Resistant Epithelial Ovarian Cancer—A Study of the GANNET53 Consortium

    Isabelle Ray-Coquard; Ioana Braicu; Regina Berger et al.

    Frontiers in Oncology, Vol. 9 · 2019 · English · DOAJ Scopus

    Background: Stabilized mutant p53 protein (mutp53) is a novel target in epithelial ovarian cancer. Due to aberrant conformation, mutp53 proteins depend on folding support by the Hsp90 chaperone. Hsp90 blockade induces degradation of mutp53, resulting in tumor cell cytotoxicity and increased…

  13. Journal Article

    Nucleosome footprinting in plasma cell-free DNA for the pre-surgical diagnosis of ovarian cancer

    Adriaan Vanderstichele; Pieter Busschaert; Chiara Landolfo et al.

    npj Genomic Medicine, Vol. 7 No. 1 · 2022 · English · DOAJ Scopus

    Abstract Fragmentation patterns of plasma cell-free DNA (cfDNA) are known to reflect nucleosome positions of cell types contributing to cfDNA. Based on cfDNA fragmentation patterns, the deviation in nucleosome footprints was quantified between diagnosed ovarian cancer patients and healthy…